AI Drug Discovery: From Insights to Impact
Schedule
Thu Mar 13 2025 at 06:00 pm to 09:00 pm
UTC+08:00Location
Bridge+ by TWP - Ascent | Coworking & Office Space | Queenstown, SG
About this Event
WuXi AppTec is pleased to invite a panel of distinguished industry experts on AI and drug discovery. Join us for an engaging discussion on the forefront of artificial intelligence and its real-life applications towards the biotech industry.
Our speakers include:
- John Ng, General Manager of Dark Horse Consulting Group, former CTO and acting CEO of Tessa Therapeutics
- Sean Sen Lin, Cofounder and CEO of Chemlex, a startup focusing on chemical synthesis with a proprietary high-throughput fully-automated system
- Dr Ling Wu, President of ChemT, & Jie Sun, CEO of ChemT, an AI-driven TechBio that designs cellular drugs for biologics
- Additional speakers to be confirmed
The event will feature a keynote speech by John Ng, followed by a panel discussion moderated by Dr Fangxin Li from WuXi AppTec's strategic investment team. Buffet will be provided.
About WuXi AppTec Solitaire Initiative:
Solitaire Initiative is a sponsored research programme setup by WuXi AppTec, a global CRDMO (contract research, development and manufacturing organisation). We support Singapore researchers in the area of novel therapeutics and bio-manufacturing. Find out more by speaking to us or contact [email protected]
About WuXi AppTec:
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
Where is it happening?
Bridge+ by TWP - Ascent | Coworking & Office Space, 2 Science Park Drive, Queenstown, SingaporeUSD 0.00
